Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
17.89
-1.03 (-5.45%)
Nov 21, 2024, 12:24 PM EST - Market open
Capricor Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CAPR stock have an average target of 39.29, with a low estimate of 25 and a high estimate of 77. The average target predicts an increase of 119.62% from the current stock price of 17.89.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CAPR stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 4 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +123.59% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +330.41% | Nov 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $25 → $30 | Buy | Maintains | $25 → $30 | +67.69% | Nov 14, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $35 | Buy | Initiates | $35 | +95.64% | Oct 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $77 | Strong Buy | Maintains | $40 → $77 | +330.41% | Oct 11, 2024 |
Financial Forecast
Revenue This Year
16.48M
from 25.18M
Decreased by -34.57%
Revenue Next Year
38.80M
from 16.48M
Increased by 135.53%
EPS This Year
-1.40
from -0.83
EPS Next Year
-0.83
from -1.40
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 20.9M | 150.7M | 170.5M | ||
| Avg | 16.5M | 38.8M | 109.2M | ||
| Low | 8.7M | n/a | 56.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -17.0% | 814.6% | 339.5% | ||
| Avg | -34.6% | 135.5% | 181.3% | ||
| Low | -65.4% | - | 45.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.32 | 1.61 | 1.68 | ||
| Avg | -1.40 | -0.83 | 0.64 | ||
| Low | -1.58 | -1.55 | -0.28 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.